Onconetix, INC. (ONCO) — 8-K Filings

All 8-K filings from Onconetix, INC.. Browse 44 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (44)

Onconetix 8-K Signals Potential Leadership/Comp Changes — Mar 24, 2026
Onconetix, Inc. filed an 8-K on March 24, 2026, reporting events from March 18, 2026, under Item 5.02, which typically covers changes in directors or officers a
Onconetix, Inc. Files Material Definitive Agreement — Dec 10, 2025 Risk: medium
Onconetix, Inc. (formerly Blue Water Biotech, Inc.) entered into a material definitive agreement on December 6, 2025. The company, incorporated in Delaware with
Onconetix, Inc. Reports Shareholder Nomination Event — Oct 29, 2025 Risk: low
Onconetix, Inc. filed an 8-K on October 29, 2025, reporting a shareholder nomination event that occurred on October 23, 2025. The company, formerly known as Blu
Onconetix, Inc. Files 8-K: Material Agreement & Equity Sales — Oct 3, 2025 Risk: medium
Onconetix, Inc. reported on October 3, 2025, regarding events that occurred on October 1, 2025. The filing indicates an entry into a material definitive agreeme
Onconetix, Inc. Reports Material Agreement Changes & Equity Sales — Sep 26, 2025 Risk: medium
Onconetix, Inc. filed an 8-K on September 26, 2025, reporting on events that occurred on September 22, 2025. The filing indicates an entry into and termination
Onconetix, Inc. Files 8-K for Material Agreement — Sep 22, 2025 Risk: medium
Onconetix, Inc. filed an 8-K on September 22, 2025, reporting a material definitive agreement entered into on September 17, 2025. The filing also includes Regul
Onconetix, Inc. Reports Material Agreement and Financial Obligation — Sep 4, 2025 Risk: medium
Onconetix, Inc. filed an 8-K on September 4, 2025, reporting a material definitive agreement and a direct financial obligation. The filing date of the earliest
Onconetix, Inc. Files 8-K: Agreements, Financial Obligations, and Officer Changes — Aug 12, 2025 Risk: medium
Onconetix, Inc. announced on August 12, 2025, that it entered into a material definitive agreement on August 6, 2025. The company also reported the creation of
Onconetix, Inc. Files 8-K with Material Agreements and Officer Changes — Jul 16, 2025 Risk: medium
Onconetix, Inc. filed an 8-K on July 16, 2025, reporting on several key events. These include entering into a material definitive agreement, changes in director
Onconetix, Inc. Files 8-K with Regulatory Updates — Jun 16, 2025 Risk: low
Onconetix, Inc. filed an 8-K on June 16, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Blue W
Onconetix, Inc. Files 8-K on Material Agreement — Jun 11, 2025 Risk: medium
Onconetix, Inc. filed an 8-K on June 11, 2025, reporting a material definitive agreement and a direct financial obligation. The company, formerly known as Blue
Onconetix, Inc. Files 8-K on Shareholder Votes and Financials — Jun 5, 2025 Risk: low
Onconetix, Inc. filed an 8-K on June 5, 2025, reporting on matters submitted to a vote of security holders and financial statements as of May 30, 2025. The comp
Onconetix, Inc. Files 8-K: Material Agreement, Financial Obligation, Delisting Notice — May 22, 2025 Risk: high
Onconetix, Inc. filed an 8-K on May 22, 2025, reporting a material definitive agreement, a direct financial obligation, and a notice of delisting or failure to
Onconetix Faces Delisting Concerns — Apr 30, 2025 Risk: high
Onconetix, Inc. filed an 8-K on April 30, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule. The company, formerly known as B
Onconetix Faces Delisting Concerns — Apr 18, 2025 Risk: high
Onconetix, Inc. (formerly Blue Water Biotech, Inc.) filed an 8-K on April 18, 2025, reporting a notice of delisting or failure to satisfy a continued listing ru
Onconetix, Inc. Files 8-K Report — Apr 8, 2025 Risk: low
Onconetix, Inc. filed an 8-K on April 8, 2025, reporting other events and financial statements. The company, formerly known as Blue Water Biotech, Inc. and Blue
Onconetix, Inc. Files 8-K on Officer/Director Changes — Apr 3, 2025 Risk: medium
Onconetix, Inc. filed an 8-K on April 3, 2025, reporting on events that occurred on March 28, 2025. The filing pertains to the departure of directors or certain
Onconetix, Inc. Files 8-K: Standard Disclosure — Mar 24, 2025 Risk: low
Onconetix, Inc. filed an 8-K on March 24, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Blue
Onconetix, Inc. Files 8-K for Disclosure and Exhibits — Mar 19, 2025 Risk: low
Onconetix, Inc. filed an 8-K on March 19, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as Blue
Onconetix Announces Material Agreement and Officer Changes — Feb 28, 2025 Risk: medium
Onconetix, Inc. announced on February 24, 2025, the entry into a material definitive agreement and changes in its board and officer composition. The company als
Onconetix, Inc. Files 8-K: Agreements, Financial Obligations, and Personnel Changes — Feb 18, 2025 Risk: medium
Onconetix, Inc. (formerly Blue Water Biotech, Inc.) announced on February 12, 2025, a material definitive agreement and a direct financial obligation. The compa
Onconetix Faces Delisting Concerns — Jan 24, 2025 Risk: high
Onconetix, Inc. filed an 8-K on January 24, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard, with the effective
Onconetix, Inc. Files 8-K — Jan 22, 2025 Risk: low
Onconetix, Inc. filed an 8-K on January 22, 2025, reporting an event that occurred on January 15, 2025. The filing is categorized under 'Other Events' and inclu
Onconetix Faces Delisting Concerns — Dec 12, 2024 Risk: high
Onconetix, Inc. filed an 8-K on December 12, 2024, reporting a notice of delisting or failure to satisfy continued listing rules. The company was formerly known
Onconetix, Inc. Files 8-K for Material Agreement — Dec 3, 2024 Risk: medium
Onconetix, Inc. (formerly Blue Water Biotech, Inc.) entered into a material definitive agreement on November 26, 2024. The filing does not disclose the specific
Onconetix, Inc. Reports Change in Certifying Accountant — Oct 21, 2024 Risk: medium
Onconetix, Inc. (formerly Blue Water Biotech, Inc.) filed an 8-K on October 21, 2024, reporting a change in its certifying accountant as of October 15, 2024. Th
Onconetix, Inc. Files 8-K: Material Agreement & Equity Sales — Oct 3, 2024 Risk: medium
Onconetix, Inc. (formerly Blue Water Biotech, Inc.) entered into a material definitive agreement on October 2, 2024. The company also disclosed unregistered sal
Onconetix Faces Delisting Concerns — Sep 24, 2024 Risk: high
Onconetix, Inc. filed an 8-K on September 24, 2024, reporting a notice of delisting or failure to satisfy a continued listing rule. The company previously opera
Onconetix, Inc. Files 8-K for Security Holder Rights Changes — Sep 20, 2024 Risk: medium
Onconetix, Inc. filed an 8-K on September 20, 2024, reporting material modifications to security holder rights and amendments to its articles of incorporation o
Onconetix, Inc. Files 8-K on Shareholder Votes & Financials — Sep 11, 2024 Risk: low
Onconetix, Inc. filed an 8-K on September 11, 2024, reporting on matters submitted to a vote of security holders and financial statements as of September 5, 202
Onconetix, Inc. Files 8-K — Sep 5, 2024 Risk: low
Onconetix, Inc. filed an 8-K on September 4, 2024, reporting other events and financial statements. The company, formerly known as Blue Water Biotech, Inc. and
Onconetix, Inc. Files 8-K with Exhibit Details — Sep 3, 2024 Risk: low
Onconetix, Inc. filed an 8-K on September 3, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing also notes the company's former
Onconetix Reports Shareholder Nominations — Aug 7, 2024 Risk: medium
Onconetix, Inc. filed an 8-K on August 7, 2024, reporting shareholder nominations pursuant to Exchange Act Rule 14a-11. The filing indicates that the company, f
Onconetix, Inc. Files 8-K — Jul 15, 2024 Risk: low
Onconetix, Inc. filed an 8-K on July 15, 2024, reporting other events and financial statements. The company, formerly known as Blue Water Biotech, Inc. and Blue
Onconetix, Inc. Files 8-K: Material Agreement & Equity Sales — Jul 11, 2024 Risk: medium
Onconetix, Inc. announced on July 11, 2024, that it entered into a Material Definitive Agreement. The company also reported on unregistered sales of equity secu
Onconetix, Inc. Announces Board and Compensation Changes — Jun 13, 2024 Risk: low
Onconetix, Inc. announced on June 8, 2024, a change in its board of directors and executive compensation arrangements. The company, formerly known as Blue Water
Onconetix, Inc. Faces Delisting Concerns — May 13, 2024 Risk: high
Onconetix, Inc. filed an 8-K on May 13, 2024, reporting a Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard. The company was former
Onconetix, Inc. Enters Material Definitive Agreement — Apr 26, 2024 Risk: medium
Onconetix, Inc. (formerly Blue Water Biotech, Inc.) announced on April 24, 2024, that it entered into a material definitive agreement. The company, incorporated
Onconetix, Inc. Files 8-K Reporting Event — Apr 8, 2024 Risk: medium
Onconetix, Inc. filed an 8-K on April 8, 2024, reporting an event that occurred on March 27, 2024. The filing indicates a change in the company's status or oper
Onconetix Reports Officer/Director Changes, Compensation on Feb 8 — Feb 13, 2024 Risk: medium
Onconetix, Inc. filed an 8-K on February 13, 2024, reporting events that occurred on February 8, 2024. The filing indicates changes in its board of directors or
Onconetix 8-K: Administrative Update, Name Change History Noted — Feb 12, 2024 Risk: low
Onconetix, Inc. filed an 8-K on February 12, 2024, reporting an event that occurred on February 6, 2024. This filing primarily updates administrative informatio
Onconetix Sells Unregistered Equity, Enters Material Agreement — Jan 29, 2024
On January 23, 2024, Onconetix, Inc. entered into a material definitive agreement and completed unregistered sales of equity securities. This filing indicates t
Onconetix Reports Officer/Director Changes & Comp Arrangements — Jan 19, 2024
Onconetix, Inc. filed an 8-K on January 19, 2024, reporting an event that occurred on January 17, 2024, related to the departure or election of directors/office
Onconetix 8-K: Leadership Changes & Compensation Arrangements — Jan 12, 2024
On January 10, 2024, Onconetix, Inc. filed an 8-K to report the departure of directors or certain officers and the election of new directors or appointment of c

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX